183 related articles for article (PubMed ID: 34927277)
1. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality.
Higuchi M; Tamaki N; Kurosaki M; Inada K; Kirino S; Yamashita K; Hayakawa Y; Osawa L; Takaura K; Maeyashiki C; Kaneko S; Yasui Y; Takahashi Y; Tsuchiya K; Nakanishi H; Itakura J; Loomba R; Enomoto N; Izumi N
Aliment Pharmacol Ther; 2022 Feb; 55(3):292-301. PubMed ID: 34927277
[TBL] [Abstract][Full Text] [Related]
2. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
Ichikawa S; Motosugi U; Enomoto N; Onishi H
Eur Radiol; 2019 Feb; 29(2):1013-1021. PubMed ID: 30043162
[TBL] [Abstract][Full Text] [Related]
4. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee SW; Huang DQ; Bettencourt R; Ajmera V; Tincopa M; Noureddin N; Amangurbanova M; Siddiqi H; Madamba E; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Yoneda M; Idilman R; Gumussoy M; Oz DK; Erden A; Loomba R
Aliment Pharmacol Ther; 2024 Jan; 59(1):80-88. PubMed ID: 37968251
[TBL] [Abstract][Full Text] [Related]
5. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease.
Lee DH; Lee JM; Chang W; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2018 Aug; 28(8):3513-3521. PubMed ID: 29488082
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study.
Gidener T; Yin M; Dierkhising RA; Allen AM; Ehman RL; Venkatesh SK
Hepatology; 2022 Feb; 75(2):379-390. PubMed ID: 34510513
[TBL] [Abstract][Full Text] [Related]
9. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
Eaton JE; Sen A; Hoodeshenas S; Schleck CD; Harmsen WS; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1576-1583.e1. PubMed ID: 31683058
[TBL] [Abstract][Full Text] [Related]
10. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography.
Kobayashi T; Iwaki M; Nogami A; Kawamura N; Honda Y; Ogawa Y; Imajo K; Yoneda M; Saito S; Nakajima A
J Gastroenterol; 2024 Jan; 59(1):56-65. PubMed ID: 37845417
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals.
Tamaki N; Higuchi M; Kurosaki M; Kirino S; Osawa L; Watakabe K; Wang W; Okada M; Shimizu T; Takaura K; Takada H; Kaneko S; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Enomoto N; Izumi N
J Viral Hepat; 2019 Jul; 26(7):893-899. PubMed ID: 30974045
[TBL] [Abstract][Full Text] [Related]
12. Can MR elastography be used to measure liver stiffness in patients with iron overload?
Serai SD; Trout AT
Abdom Radiol (NY); 2019 Jan; 44(1):104-109. PubMed ID: 30066167
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
14. Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma.
Chou CT; Chen RC; Wu WP; Lin PY; Chen YL
Ultrasound Med Biol; 2017 Dec; 43(12):2783-2790. PubMed ID: 28965721
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Liver Stiffness Measurement by Magnetic Resonance Elastography for Complications after Liver Resection: A Systematic Review and Meta-Analysis.
Liang J; Qiu B; Yin S; Chen Y; Zhang S
Digestion; 2022; 103(5):357-366. PubMed ID: 35780768
[TBL] [Abstract][Full Text] [Related]
16. Performance of magnetic resonance elastography in primary sclerosing cholangitis.
Eaton JE; Dzyubak B; Venkatesh SK; Smyrk TC; Gores GJ; Ehman RL; LaRusso NF; Gossard AA; Lazaridis KN
J Gastroenterol Hepatol; 2016 Jun; 31(6):1184-90. PubMed ID: 26691631
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease.
Hartung EA; Calle-Toro JS; Lopera CM; Wen J; Carson RH; Dutt M; Howarth K; Furth SL; Darge K; Serai SD
Abdom Radiol (NY); 2021 Feb; 46(2):570-580. PubMed ID: 32757071
[TBL] [Abstract][Full Text] [Related]
18. Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis.
Anaparthy R; Talwalkar JA; Yin M; Roberts LR; Fidler JL; Ehman RL
Aliment Pharmacol Ther; 2011 Jul; 34(1):83-91. PubMed ID: 21535445
[TBL] [Abstract][Full Text] [Related]
19. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: from diagnosis to prognosis.
Liang J; Ampuero J; Castell J; Zhang Q; Zhang S; Chen Y; Romero-Gómez M
Ann Hepatol; 2023; 28(2):100889. PubMed ID: 36572210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]